Updated Jan 16, 2018

Default inno

The use of a permanent make-up (or tattoo) device to target drug delivery against cutaneous leishmaniasis.

https://www.mcgill.ca/

The innovation has no owner

CLAIM IT

Stage 2: Research & Development

Registered in Canada.

Focus Areas:

Health, Prevention & Vaccination, Human Centered Design and 1 MoreSEE ALL

Health, Prevention & Vaccination, Human Centered Design and TechnologySEE LESS

Implemented In:

Iran

IranSEE LESS

1
Country Implemented In
Verified Funding
?

Innovation Description

The proposed idea is to use a permanent make-up device to target intra-dermal administration of an anti-cutaneous leishmaniasis therapy and deliver and concentrate the drug in professional phagocytes.
How does your innovation work?
The proposed idea is to use a permanent make-up (or tattoo) device, a proven technology of the cosmetic sector, to a) target intra-dermal administration of an anti-cutaneous leishmaniasis therapy, and b) deliver and concentrate the drug in professional phagocytes, the exclusive replicative niche of the leishmania parasites.

Milestones

Date Unknown
Created
Date Unknown
New Country Implemented In
Iran